These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 24029412)

  • 1. Cognitive patterns in relation to biomarkers of cerebrovascular disease and vascular risk factors.
    Miralbell J; López-Cancio E; López-Oloriz J; Arenillas JF; Barrios M; Soriano-Raya JJ; Galán A; Cáceres C; Alzamora M; Pera G; Toran P; Dávalos A; Mataró M
    Cerebrovasc Dis; 2013; 36(2):98-105. PubMed ID: 24029412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion tensor imaging, intracranial vascular resistance and cognition in middle-aged asymptomatic subjects.
    López-Olóriz J; López-Cancio E; Arenillas JF; Hernández M; Dorado L; Dacosta-Aguayo R; Barrios M; Soriano-Raya JJ; Miralbell J; Bargalló N; Cáceres C; Torán P; Alzamora M; Dávalos A; Mataró M
    Cerebrovasc Dis; 2014; 38(1):24-30. PubMed ID: 25196863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular risk factors and cognitive functions in nondemented elderly individuals.
    Wiederkehr S; Laurin D; Simard M; Verreault R; Lindsay J
    J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):196-206. PubMed ID: 19487580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymptomatic cervicocerebral atherosclerosis, intracranial vascular resistance and cognition: the AsIA-neuropsychology study.
    López-Olóriz J; López-Cancio E; Arenillas JF; Hernández M; Jiménez M; Dorado L; Barrios M; Soriano-Raya JJ; Miralbell J; Cáceres C; Forés R; Pera G; Dávalos A; Mataró M
    Atherosclerosis; 2013 Oct; 230(2):330-5. PubMed ID: 24075765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired cognitive performance in asymptomatic peripheral arterial disease: relation to C-reactive protein and D-dimer levels.
    Mangiafico RA; Sarnataro F; Mangiafico M; Fiore CE
    Age Ageing; 2006 Jan; 35(1):60-5. PubMed ID: 16364935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural brain changes and cognition in relation to markers of vascular dysfunction.
    Miralbell J; Soriano JJ; Spulber G; López-Cancio E; Arenillas JF; Bargalló N; Galán A; Barrios MT; Cáceres C; Alzamora MT; Pera G; Kivipelto M; Wahlund LO; Dávalos A; Mataró M
    Neurobiol Aging; 2012 May; 33(5):1003.e9-17. PubMed ID: 22014619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of low-grade inflammation and endothelial dysfunction are related to reduced information processing speed and executive functioning in an older population - the Hoorn Study.
    Heringa SM; van den Berg E; Reijmer YD; Nijpels G; Stehouwer CD; Schalkwijk CG; Teerlink T; Scheffer PG; van den Hurk K; Kappelle LJ; Dekker JM; Biessels GJ
    Psychoneuroendocrinology; 2014 Feb; 40():108-18. PubMed ID: 24485482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum C-reactive protein is linked to cerebral microstructural integrity and cognitive function.
    Wersching H; Duning T; Lohmann H; Mohammadi S; Stehling C; Fobker M; Conty M; Minnerup J; Ringelstein EB; Berger K; Deppe M; Knecht S
    Neurology; 2010 Mar; 74(13):1022-9. PubMed ID: 20350977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Executive dysfunction in vascular cognitive impairment in the consortium to investigate vascular impairment of cognition study.
    Moorhouse P; Song X; Rockwood K; Black S; Kertesz A; Gauthier S; Feldman H;
    J Neurol Sci; 2010 Jan; 288(1-2):142-6. PubMed ID: 19840883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive function in late life depression: relationships to depression severity, cerebrovascular risk factors and processing speed.
    Sheline YI; Barch DM; Garcia K; Gersing K; Pieper C; Welsh-Bohmer K; Steffens DC; Doraiswamy PM
    Biol Psychiatry; 2006 Jul; 60(1):58-65. PubMed ID: 16414031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic syndrome, atherosclerosis and cognitive functioning in a non-demented population: the Hoorn Study.
    Reijmer YD; van den Berg E; Dekker JM; Nijpels G; Stehouwer CD; Kappelle LJ; Biessels GJ
    Atherosclerosis; 2011 Dec; 219(2):839-45. PubMed ID: 21959256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular, inflammatory, and metabolic factors associated with cognition in aging persons with chronic epilepsy.
    Hermann BP; Sager MA; Koscik RL; Young K; Nakamura K
    Epilepsia; 2017 Nov; 58(11):e152-e156. PubMed ID: 28872189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological signatures of asymptomatic extra- and intracranial atherosclerosis: the Barcelona-AsIA (Asymptomatic Intracranial Atherosclerosis) study.
    López-Cancio E; Galán A; Dorado L; Jiménez M; Hernández M; Millán M; Reverté S; Suñol A; Barallat J; Massuet A; Alzamora MT; Dávalos A; Arenillas JF
    Stroke; 2012 Oct; 43(10):2712-9. PubMed ID: 22798326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vascular risk factors and cognitive performance in patients 50 to 65 years-old].
    Miralbell J; Soriano JJ; López-Cancio E; Arenillas JF; Dorado L; Barrios M; Cáceres C; Alzamora MT; Torán P; Pera G; Dávalos A; Mataró M
    Neurologia; 2010 Sep; 25(7):422-9. PubMed ID: 20964988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage inhibitory cytokine-1 is associated with cognitive impairment and predicts cognitive decline - the Sydney Memory and Aging Study.
    Fuchs T; Trollor JN; Crawford J; Brown DA; Baune BT; Samaras K; Campbell L; Breit SN; Brodaty H; Sachdev P; Smith E
    Aging Cell; 2013 Oct; 12(5):882-9. PubMed ID: 23758647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal levels of brain metabolites may mediate cognitive impairment in stroke-free patients with cerebrovascular risk factors.
    Sun D; Zhang J; Fan Y; Liu X; Gao Y; Wu G; Yan Y; Zeng J
    Age Ageing; 2014 Sep; 43(5):681-6. PubMed ID: 24614642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of metabolic syndrome components to cognition in older individuals.
    Dik MG; Jonker C; Comijs HC; Deeg DJ; Kok A; Yaffe K; Penninx BW
    Diabetes Care; 2007 Oct; 30(10):2655-60. PubMed ID: 17563341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum high sensitivity C-reactive protein and cognitive function in elderly women.
    Komulainen P; Lakka TA; Kivipelto M; Hassinen M; Penttilä IM; Helkala EL; Gylling H; Nissinen A; Rauramaa R
    Age Ageing; 2007 Jul; 36(4):443-8. PubMed ID: 17537742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment and frontal-subcortical geriatric syndrome are associated with metabolic syndrome in a stroke-free population.
    Roriz-Cruz M; Rosset I; Wada T; Sakagami T; Ishine M; De Sá Roriz-Filho J; Cruz TR; Hosseinkhani M; Rodrigues RP; Sudoh S; Arai H; Wakatsuki Y; Souza AC; Nakagawa M; Kita T; Matsubayashi K
    Neurobiol Aging; 2007 Nov; 28(11):1723-36. PubMed ID: 16962212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.